论文部分内容阅读
目的分析利奈唑胺治疗医院获得性耐甲氧西林金黄色葡萄球菌肺炎效果。方法选取MRSA肺炎患者共50例,随机将其分成观察组和对照组各25例,其中观察组患者使用利奈唑胺治疗,对照组患者采用万古霉素进行治疗,对两组患者的治疗效果进行分析对比。结果观察组患者18例痊愈,2例显效,3例有效,2例无效,总有效率为80%;对照组患者10例痊愈,3例显效,4例有效,8例无效,总有效率为52%。两组患者在总有效率上差异具有统计学意义(P<0.05)。结论在治疗医院获得性耐甲氧西林金黄色葡萄球菌肺炎时,使用利奈唑胺治疗效果明显优于万古霉素,患者治愈率较高且不良反应少,在临床上值得广泛使用。
Objective To analyze the efficacy of linezolid in the treatment of hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia. Methods A total of 50 patients with MRSA pneumonia were selected and randomly divided into observation group and control group, with 25 cases in each group. The patients in observation group were treated with linezolid and the patients in control group were treated with vancomycin. The therapeutic effect of two groups of patients Analysis and comparison. Results In the observation group, 18 cases were cured, 2 cases were effective, 3 cases were effective, 2 cases were ineffective and the total effective rate was 80%. In the control group, 10 cases were cured, 3 cases were effective, 4 cases were effective and 8 cases were ineffective. The total effective rate was 52%. The two groups of patients in the total effective rate difference was statistically significant (P <0.05). Conclusions Linezolid is superior to vancomycin in the treatment of hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia. It has a high cure rate and few side effects and is worth widely used in clinical practice.